
Mary Lou Schmidt MD
Associate Professor, Pediatrics, University of Illinois College of Medicine
Join to View Full Profile
1740 W Taylor StChicago, IL 60612
Phone+1 866-660-2273
Fax+1 312-413-9484
Dr. Schmidt is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Robert H. Lurie Cancer Center, Northwestern University Medical SchoolResearch Fellowship, 1989 - 1992
McGaw Medical Center of Northwestern UniversityFellowship, Pediatric Hematology/Oncology, 1988 - 1992
Children’s Memorial Hospital, Northwestern UniversityClinical Fellowship, 1988 - 1989
McGaw Medical Center of Northwestern UniversityResidency, Pediatrics, 1986 - 1988
McGaw Medical Center of Northwestern UniversityInternship, Pediatrics, 1985 - 1986
Certifications & Licensure
IL State Medical License 1987 - 2026
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Gold Foundation Humanism Faculty Award (national nominee) UIC College of Medicine, 2011
- Best Doctors in America 2011
Clinical Trials
- Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma Start of enrollment: 2001 Oct 26
- Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET Start of enrollment: 2007 May 23
- Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma Start of enrollment: 2007 Oct 08
Publications & Presentations
PubMed
- Diet and Exercise Interventions in Pediatric Cancer Survivors and Effects on Cardiometabolic Disease Risk and Inflammaging Biomarkers: A Systematic Review.Kate Cares, Alyssa Bryner, Brittany DiPiazza, Kaitlin Chakos, Mary Lou Schmidt
Advances in Nutrition. 2026-04-01 - 3 citationsLong-Term Outcome of Young Infants With Suspected Neuroblastoma following Observation as Primary Therapy: A Report From the Children's Oncology Group.Hetal Dholaria, Arlene Naranjo, Fan F Zhang, Wendy B London, Lisa Diller
Pediatric Blood & Cancer. 2025-08-01 - 4 citationsEvaluation of Image-Defined Risk Factor (IDRF) Assessment in Patients With Intermediate-risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL0531.Erin G Brown, E Stanton Adkins, Peter Mattei, Fredric A Hoffer, Sandra L Wootton-Gorges
Journal of Pediatric Surgery. 2025-01-01
Journal Articles
- Ototoxicity in Children with High Risk Neuroblastoma-Prevalence, Risk Factors and Concordance of Grading Scales: A Report from the Children’s Oncology Group.Landier W, Knight K, Wong L, Lee J, Thomas O, Kiim H, Kreissman S, Schmidt ML, Chen L, London W, Gurney J, Bhatia S, Journal of Clinical Oncology, 5/1/2013
- A Prospective Study of Expectant Observation as Primary Therapy for Neuroblastoma in Young Infants: A Children’s Oncology Group Study.Nuchtern JG, London WB, Barnewolt CE, Naranjo A, McGrady PW, Geiger JD, Diller L, Schmidt ML, Maris JM, Cohn SL, Shamberger RC, Annals of Surgery, 10/1/2012
- Outcome After Surgery Alone or With Restricted Use of Chemotherapy for Patients with Low-Risk Neuroblastoma: Results of Children’s Oncology Group Study P9641.Strother DR, London WB, Schmidt ML, Brodeur GM, Shimada H, Thorner P, Collins MH, Tagge E, Adkins S, Reynolds CP, Murray K, Lavey RS, Matthay KK, Castleberry R, Maris..., Journal of Clinical Oncology, 4/23/2012
Books/Book Chapters
Abstracts/Posters
- Data-driven Policy Recommendations to Promote the Advancement & Retention of Female Physician, Physician Scientists in the Academic Medicine Pipeline.Kwan JM, Daye D, Schmidt ML, Morrissey C, Kim H, Payne A, Quinn K, American Association of Medical Colleges Annual Meeting (Nov 2-7, 2012), 11/2/2012
- Outcome Analysis of Non-High Risk Neuroblastoma Patients Enrolled on Children’s Oncology Group Trials P9641 and A3961.Attiyeh E, , Meany H, Naranjo A, Twist C, London W, Villablanca J, Baker D, Strother DR, Schmidt ML, Maris J, Park J, The Advances in Neuroblastoma Research Conference 2012, Toronto, Ont, Canada, 6/21/2012
- Infant Metastatic (4+4S) Non-amplified Neuroblastoma has a very high survival rate with moderate dose chemotherapy.Schmidt ML, Strother D, Baker D, Naranjo A, McGrady P, London W, Shimada H, Cohn SL, Matthay KK, Maris J, The Advances in Neuroblastoma Research Conference 2012, Toronto, Ont, Canada (Jun 18-21, 2012), 6/18/2012
Professional Memberships
- Member
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









